期刊文献+

D-二聚体检测在类风湿性关节炎中的临床应用价值 被引量:4

The Clinical Application Value of D-Dimer in Rheumatoid Arthritis
下载PDF
导出
摘要 目的检测D-二聚体在类风湿性关节炎(RA)患者中的水平,了解其在RA中的临床应用价值。方法检测35(?)RA患者及30例健康人群中D-二聚体的水平,并了解其与类风湿因子(RF),血沉(ESR),C反应蛋白(CRP),血小板(PLT),抗环(?)氨酸肽抗体(抗CCP抗体)及疾病活动度(DSA28)的相关性。结果①血D-二聚体水平在RA患者中明显高于对照组(P<0.01)②相关性分析显示,D-二聚体水平与DAS28评分(r=0.462,P<0.01)、ESR(r=0.497,P<0.05)、RF(r=0.639,P<0.01)、CRP(=0.562,P<0.01)、PLT(r=0.371,P<0.05)具有相关性,与年龄及病程无明显相关性(P>0.05)。③D-二聚体在CCP阳性组与阴性组患者中无明显相关性(P>0.05)。结论 RA患者中D-二聚体水平明显升高,且与疾病活动相关,提示凝血-纤溶系统在R的发病机理及疾病转归中存在重要意义。 Objective To research the plasm level of D-Dimer in rheumatoid arthritis(RA) patients and to analyze the value of clinical application in RA. Methods Thirty-five patients with RA and 30 healthy controls were selected. D-Dimer of the two groups were de- tected. The correlations between D-Dimer and ESR, CRP, DAS28, PLT, RF and CCP were analyzed. The t-test and Spearman correlation were used for statistical analysis. Results The plasm level of D-Dimer in RA patients was higher than in the heahhy eontrnls ( P 〈 0.01 ). The plasm level of DD was obviously related to ESR ( r = 0. 497,P 〈 0.05 ), CRP( r = 0. 562, P 〈 0.01 ), DAS28 ( r = 0. 462, P 〈 0.01 ), and PLT (r = 0. 371, P 〈 0.05 ), and was negatively related to age ( r = 0. 217, P 〉 0.05 ) and disease duration ( r = 0. 156, P 〉 0.05 ). The level of D- Dimer in the positive group and negative group of CCP had no significant difference ( P 〉 0.05 ). Conclusion The plasm level of D-Dimer el- evates in the patients with RA ,and has positive correlation with disease activity. The research indicated that the coagulation-fibrinolytic system may have an important significance in the pathogenesis and prognosis of RA.
出处 《潍坊医学院学报》 2013年第3期205-206,共2页 Acta Academiae Medicinae Weifang
关键词 关节炎 类风湿 D-二聚体 病情活动 Arthritis Rheumatoid D-Dimer Disease activity
  • 相关文献

参考文献10

  • 1李春,穆荣,任立敏,范文强,任长吉,栗占国.D-二聚体水平在系统性红斑狼疮的临床意义[J].中华内科杂志,2010,49(12):1039-1042. 被引量:25
  • 2Bloom BJ,Tucker LB,Miller LC,et al. Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis [ J ]. J Rheumatol, 1998,25 ( 8 ) : 1620 - 1625.
  • 3So AK,Variseo PA, Kemkes-Matthes B, et al. Arthritis is linked to lacal and systemic activation of coagulation and fibrinolysis pathways [J]. J Thmmb Hacmost ,2003, 1:2510 - 2515.
  • 4Jin T, Bokarewa M, Ainu S, et al. Impact of short-term therapies with biologics on prothrombotie biomarkers in rhcumatoid arthritis[J]. Clin Exp Rheumatol,2009,27 ( 3 ) :491 - 494.
  • 5Ingegnoli F, Fantini F, Favalli EG, et al. Inflammatory and prothrom+ botie biomarkers in patients with rheumatoid arthritis;effecots of tumor necrosis factor-alpha blockade[J]. J Autoimmun ,2008,31 ( 2 ) : 175 179.
  • 6Robson SC,Shephard EG,Kitsch RE. Fibrin degradalion produet D-dimet induces the synthesis and release of biologieatly active IL-1 beta IL-6 and plasminogen activator inhibitors from monacyte in vitro [J]. Br J Huematol , 1994,86:322 - 326.
  • 7Zacharski LR, Brown FE, Memoli VA, et al. Pathway of coagulation activation in situ in rheumatoid synovial tissue [J]. Clin hn Munopathol, 1992,63 : 155 - 162.
  • 8Robson SC, Shephard EG, Kitsch RE. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta IL-6 and plasminogen activator inhibitors from monacyte in vitro[ J ] Br J Haematol , 1994,86:322 - 326.
  • 9lshikawa H, Hirata S, Andoh Y, et al. An immunohistechemical and immunoeleetron microscopy study of adhesion molecules in synovial pannus formation in rheumatoid arthritis[J]. Rheumatol Int, 1996,16: 53 - 60.
  • 10Marry I,Peelat V, Kirdaite G, et al. Amelioration of collageninduced arthritis by thrombin inhibition [J]. J Ciin Inrest, 2001 , 107:631-640.

二级参考文献9

  • 1Inoh M,Tokuda M,Kiuchi H,et al.Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis.Arthritis Rheum,1996,39:287-291.
  • 2Rajagopalan S,Somers EC,Brook RD,et al.Endothelial cell apoptosis in systemic lupus erythematosus:a common pathway for abnormal vascular function and thrombosis propensity.Blood,2004,103:3677-3683.
  • 3Fijnheer R,Blann AD.The endothelium and coagulopathy in systemic lupus erythematosus:hyperhomocysteinemia as a developing risk factor.J Rheumatol,2003,30:1400-1402.
  • 4Fancher TL,White RH,Kravitz RL.Combined use of rapid D dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis:systematic review.BMJ,2004,329:821.
  • 5Afeltra A,Vadacca M,Conti L,et al.Thrombosis in systemic lupus erythematosus:congenital and acquired risk factors.Arthritis Rheum,2005,53:452-459.
  • 6Bloom BJ,Tucker LB,Miller LC,et al.Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis.J Rheumatol,1998,25:1620-1625.
  • 7Nakashima M,Aoyagi T,Aratake K,et al.The levels of FDP,FDP-E and D-dimer in patients with rheumatoid arthritis.Ryumachi,1998,38:793-800.
  • 8van Hylckama Vlieg A,Montes R,Rosendaal FR,et al.Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis.J Thromb Haemost,2007,5:1449-1454.
  • 9Cotran RS.American Association of Pathologists president's address.New roles for the endothelium in inflammation and immunity.Am J Pathol,1987,129:407-413.

共引文献24

同被引文献40

  • 1孙晓云,苏茵,蔡莉萨,王怀唐.类风湿关节炎伴发贫血的临床分析[J].中国实用内科杂志,2005,25(7):614-616. 被引量:20
  • 2雷莹辉,裴志刚,高国红.强直性脊柱炎并发的心脏病变[J].中国疗养医学,2007,16(6):365-365. 被引量:2
  • 3陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 4Bloom B J, Tucker L B, Miller L C, et al. Fibrin D-di- mer as a marker of disease activity in systemic onset ju- venile rheumatoid arthritis [ J ]. J Rheumatol, 1998,25 (8) :1620-1625.
  • 5van der Linden S, Valkenbnrg H A, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A propos- al for modification of the New York criteria [ J]. Arthritis Rheum, 1984,27(4) :361-368.
  • 6Garrett S, Jenkinson T, Kennedy L G, et al. A new ap- proach to defining disease status in ankylosing spondyli- tis: the Bath ankylosing spondylitis disease activity index [ J ]. J Rheumatol, 1994,21 ( 12 ) : 2286-2291.
  • 7Davidson S I, Wu X, Liu Y, et al. Association of ER- AP1 ,but not IL-23R, with ankylosing spondy].itis in a Han Chinese population [ J ]. Arthritis Rheum, 2009,60 ( 11 ) :3263-3268.
  • 8Davidson S l, Liu Y, Danoy P A, et al. Association of STAT3 and TNFRSF1 A with ankylosing spondylitis in Han Chinese[J]. Ann Rheum Dis, 2011,70(2):289- 292.
  • 9Lautermann D, Braun J. Ankylosing spondylitis-cardiac manifestations [ J 1- Clin Exp Bhrumatol, 2002,20 (6 Sup- ol 28) :Sll-S15.
  • 10Senocak O, Manisali M, Ozaksoy D, et al. Lung paren- chyma changes in ankylosing spondylitis; demonstration with high resolution CT and correlation with disease dura- tion[J]. Eur J Radiol, 2003,45(2) :117-122.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部